Ausgabe 14/2021
Inhalt (14 Artikel)
Current Opinion
Drug Treatment of Heart Failure with Reduced Ejection Fraction: Defining the Role of Vericiguat
Andrew J. S. Coats, Heli Tolppanen
Open Access
Leading Article
Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease
Stefan F. H. Neys, Jasper Rip, Rudi W. Hendriks, Odilia B. J. Corneth
Open Access
Review Article
Bone Mineral Density Loss and Fracture Risk After Discontinuation of Anti-osteoporotic Drug Treatment: A Narrative Review
Laura P. B. Elbers, Hennie G. Raterman, Willem F. Lems
Letter to the Editor
Comment on: “MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19”
Song Zhang, Feng Zhu
Letter to the Editor
Reply to Zhang and Zhu “MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19”
Nadine Ahmed, John Paul Pezacki
Correction
Correction to: Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
Jurij Hanzel, Christopher Ma, Niels Vande Casteele, Reena Khanna, Vipul Jairath, Brian G. Feagan
Open Access
Correction
Correction to: Budesonide/Glycopyrronium/Formoterol: A Review in COPD
Young-A Heo